IN / Mutual fund
Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option
150748
Net asset value
₹30.3763
Source / date
MFAPI (AMFI-sourced NAV) · 2026-10-01
Mutual fund NAV is a dated end-of-day scheme value, not an exchange-traded quote. Plans and payout options can have different NAVs. Company P/E-based scores, DCF valuation and forensic analysis do not apply to this listing; the analysis below uses the framework appropriate to its investment type.
DeepScreen investment analysis
Mutual fund analysis
Refreshed 10/3/2026, 10:22:49 AM
Scheme and process
Scheme identity, category, benchmark and plan structure from the available official and NAV sources.
- Fund house
- Axis Mutual Fund
- Scheme type
- Open Ended Schemes
- Category
- Overseas Fund of Funds - Fund of Funds investing overseas
- Plan
- Regular
- Option
- IDCW
- Launch date
- 2022-10-07T00:00:00+05:30
Performance
AMFI-published performance is preferred where available; NAV-history calculations fill the remaining periods.
- 1Y return
- 32.7%
- 3Y annualized return
- 32.65%
- 3Y rolling median
- 30.67%
Risk-adjusted quality
Official AMFI risk parameters are used when AMFI publishes them for the matched category; otherwise realized NAV-history measures are shown.
- 3Y max drawdown
- -22.13%
- 5Y max drawdown
- -22.13%
- 3Y volatility
- 18.86%
- 5Y volatility
- 18.48%
Cost and capacity
Plan costs, current size and entry/exit information where AMFI publishes it.
- Exit load
- If redeemed / switched-out within 7 Days from the date of allotment - 1%; If redeemed / switched-out after 7 days of allotment – Nil
- Minimum investment
- ₹500
- Latest NAV
- ₹30.3763
NAV history date: 2026-10-01
Scheme objective
To replicate the performance of the Nasdaq 100 TRI by investing ETFs whose primary objective is to track/replicate the performance of the Nasdaq 100 TRI, subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved
DeepScreen displays verified values returned by its current sources. Metrics without a verified value are omitted rather than shown as empty placeholder cards.
Investment FAQ
Questions about Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option
Research answers for Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option (150748) using the analysis framework appropriate to a mutual fund.
Mutual fund FAQ
- What is Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option (150748)?
- Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option is listed by DeepScreen as an Indian mutual fund scheme. Its NAV is a dated per-unit scheme value rather than an exchange-traded stock price. Use the scheme's stated category, benchmark, plan type, portfolio, manager record, risk measures and costs together when researching it.
- How should I analyze Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option?
- Start with Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option's objective and benchmark, then compare multi-year and rolling returns, drawdowns, volatility and risk-adjusted measures with relevant peers. Review portfolio concentration, manager tenure, TER, turnover and exit load where disclosed. For Indian schemes, compare Direct and Regular plans like-for-like because their expenses and NAVs can differ.
- What costs should I check for Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option?
- Check the current total expense ratio, whether the listing is a Direct or Regular plan, portfolio turnover and any applicable exit load. Costs reduce investor returns over time, so compare the correct plan and option rather than relying on a scheme name alone.
- Is Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option a good mutual fund to invest in?
- DeepScreen does not make a personalized investment recommendation. Whether Axis NASDAQ 100 US Specific Equity Passive FOF — Regular Plan · IDCW Option is suitable depends on the scheme mandate, risk, cost, portfolio, time horizon and how it fits an investor's broader financial situation. Use the analysis as research input and verify the latest scheme documents before making a decision.